Dr Lalchandani Labs Ltd Financials
Company Logo

Dr Lalchandani Labs Ltd Financial Statement

Dr Lalchandani Labs Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Dr Lalchandani Labs Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual4.45
Operating Expenses Annual3.53
Operating Profit Annual1.05
Interest Annual0.09
Depreciation0.52
Net Profit Annual0.42
Tax Annual-0.02

Dr Lalchandani Labs Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning2.29
Cash Flow from Operations0.37
Cash Flow from Investing0.06
Cash Flow from Financing0.58
Cash Flow at the End3.30

Dr Lalchandani Labs Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)21.12
PBIT Margin (%)8.54
PBT Margin (%)-83.82
Net PROFIT Margin (%)9.44
Return On Networth / Equity (%)3.08
Return On Networth /Employed (%)2.74
Return On Assets (%)3.11
Total Debt / Equity (X)0.39
Asset Turnover Ratio (%)0.33

Dr Lalchandani Labs Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual3.51
Total Current Assets Annual10.87
Non Current Assets Annual4.88
Total Shareholders Funds Annual9.96
Total Assets Annual15.75

Dr Lalchandani Labs Ltd Earning Calls

No Data Availabe

FAQS on Dr Lalchandani Labs Ltd Financials

As of Oct 6, 2025, Dr Lalchandani Labs Ltd has a market capitalization of 4.43 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Dr Lalchandani Labs Ltd is with a debt-to-equity ratio of 0.41.

In FY 2024 , Dr Lalchandani Labs Ltd recorded a total revenue of approximately 4.45 Cr marking a significant milestone in the company's financial performance.

Dr Lalchandani Labs Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.5% and -0.1% annually, respectively..

Dr Lalchandani Labs Ltd's current PE ratio is 10.55.

Dr Lalchandani Labs Ltd's ROCE averaged 2.3% from the FY ending March 2023 to 2025, with a median of 3.5%. It peaked at 7.7% in March 2024, reflecting strong capital efficiency over the period..

Dr Lalchandani Labs Ltd's latest EBIT is Rs. 0.49 Cr, surpassing the average EBIT of Rs. 0.31 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions